Here, we examined for IL-6-induced post-translational modifications associated with MSH3 cytosolic translocation.<h4>Methods</h4>We utilized MSH3-genotyped colon cancer cell lines after IL-6 treatment to assess post-translational modification of MSH3 via Western blots (WB). The gene discussed is MSH3; the disease is malignant colon neoplasm.